C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study
Article 2005 en
Authors
PW
Peter W.F. Wilson
BN
Byung‐Ho Nam
MP
Michael Pencina
Abstract
1 min read
Elevated CRP level provided no further prognostic information beyond traditional office risk factor assessment to predict future major CVD and major coronary heart disease in this population sample.
Weihua Zhang, Robert Clarke, Jemma C. Hopewell, John F. Peden, Jeanette Erdmann, Peter S. Braund, James C. Engert, Derrick Bennett, Lachlan Coin, Deborah Ashby, Ioanna Tzoulaki, Ian Brown, Shahrul Mt‐Isa, Mark I. McCarthy, Leena Peltonen, Nelson B. Freimer, Martin Farrall, Aimo Ruokonen, Anders Hamsten, Noha Lim, Philippe Froguel, Dawn Waterworth, Péter Vollenweider, Gérard Waeber, Paul M Ridker, Vincent Mooser, James G. Scott, Alistair S. Hall, Heribert Schunkert, Sonia S. Anand, Rory Collins, Nilesh J. Samani, Hugh Watkins, Jaspal S. Kooner, Paul Elliott, John C. Chambers
Navin Suthahar, Dongyu Wang, Joseph Pierre Aboumsallem, Canxia Shi, Sanne de Wit, Elizabeth Liu, Emily S. Lau, Stephan J. L. Bakker, Ron T. Gansevoort, Bert van der Vegt, Manol Jovani, Bernard E. Kreger, Greta Lee Splansky, Emelia Benjamin, Ramachandran S. Vasan, Martin G. Larson, Daniel Levy, Jennifer E. Ho, Rudolf A. de Boer
Thomas J. Wang, Martin G. Larson, Daniel Levy, Emelia Benjamin, Michelle J. Kupka, Warren J. Manning, Melvin E. Clouse, Ralph B. D’Agostino, Peter W.F. Wilson, Christopher J. O’Donnell
Discussion(0)
No comments yet. Be the first to comment.